InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
IWG | Ann: NetLinkz name change NET ASX code change-IWG.AX | 14/10/16 | 0 | 1.4K | |||
|
|||||||
IWG | Ann: Appendix 3B-IWG.AX | 12/10/16 | 0 | 384 | |||
|
|||||||
IWG | Ann: Prospectus-IWG.AX | 12/10/16 | 0 | 529 | |||
|
|||||||
IWG | Ann: Appendix 4G-IWG.AX | 12/10/16 | 3 | 1.5K | |||
|
|||||||
IWG | Ann: Results of General Meeting-IWG.AX | 11/10/16 | 0 | 327 | |||
|
|||||||
IWG | SD-WAN substantial market | 05/10/16 | 12 | 3.6K | |||
|
|||||||
IWG | Ann: Final Director's Interest Notice-IWG.AX | 05/10/16 | 0 | 238 | |||
|
|||||||
IWG | Ann: Final Director's Interest Notice-IWG.AX | 05/10/16 | 0 | 189 | |||
|
See All Discussions